MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • MDS Virtual Congress 2021

    Using smartphone data to infer social behaviour in Parkinson’s: proof of principle and the impact of COVID19

    H. Zhang, E. Poliakoff, B. Parsia, S. Harper (Manchester, United Kingdom)

    Objective: To investigate the potential of using smartphone data to infer changes in social behaviour in people with Parkinson's and how this has been impacted…
  • MDS Virtual Congress 2021

    Association between emotional/cognitive factors and postural control in individuals with Parkinson’s disease and freezing of gait

    CN. de Oliveira, ACL. de Lima-Pardini, C. Souza, R. Marquesini, LA. Teixeira, CS. Silva-Batista, DB. Coelho (Sp, Brazil)

    Objective: To investigate the association between emotional/cognitive factors and the parameters of postural control of patients with Parkinson’s disease (PD) and freezing of gait (FoG).…
  • MDS Virtual Congress 2021

    Neuropsychiatric Issues in Parkinson’s Disease

    F. Aziouaz, Y. Mebrouk (Oujda, Morocco)

    Objective: The aim of this study is to analyze the epidemiology, clinical features and treatment approaches for NPS in PD. Background: Parkinson's disease (PD) is…
  • MDS Virtual Congress 2021

    Effects of dopaminergic medication on reinforcement learning in Parkinson’s disease depend on depressive symptoms

    J. Tichelaar, C. Sayali, R. Helmich, R. Cools (Nijmegen, Netherlands)

    Objective: To investigate the effect of depression and dopaminergic medication on reinforcement learning (RL) in Parkinson’s disease. Background: Dopaminergic medication in PD is known to…
  • MDS Virtual Congress 2021

    Effect of COVID-19 stressors on mental health and quality of life in Parkinson’s disease

    L. Dommershuijsen, A. Heide, E. Berg, J. Labrecque, M K. Ikram, M A. Ikram, B. Bloem, R. Helmich, S. Darweesh (Nijmegen, Netherlands)

    Objective: To investigate subgroup differences in the effect of COVID-19 stressors on mental health and quality of life in people with Parkinson’s disease. Background: In…
  • MDS Virtual Congress 2021

    Longitudinal change in thalamic white matter macrostructure and volume in Parkinson’s disease depression

    R. Bhome, A. Zarkali, J. Cole, R. Weil (London, United Kingdom)

    Objective: To investigate thalamic subnuclei volume and macrostructural white matter changes in Parkinson’s disease (PD) depression. Background: Depression is the most common neuropsychiatric feature of…
  • MDS Virtual Congress 2021

    CAN DANCE AS A COMPLEMENTARY THERAPY REDUCE THE OCCURRENCE OF DEPRESSION AND APATHY IN PEOPLE WITH PARKINSON’S DISEASE?

    I. Machado, L. Fontes, B. Dos Santos-Lobato, L. Krejcova (Belém, Brazil)

    Objective: To investigate the effects of dance as complementary therapy over the presentation of depression and apathy in people with Parkinson’s Disease (PD). Background: Depression…
  • MDS Virtual Congress 2021

    Altered Resting-state Neural Activity in Parkinson’s Disease with Depression: a controlled study based on original meta-analysis results

    D. Su, Y. Cheng, J. Zhou, T. Feng (Beijing, China)

    Objective: Depression is a common non-motor symptom in Parkinson’s disease (PD), while its underlying pathophysiology remains unclear. Previous functional magnetic resonance imaging (fMRI) studies reported…
  • MDS Virtual Congress 2021

    The fear of progression of Parkinson’s Disease

    S. Mayer, E. Tekampe, A. Frank, T. Feige, H. Reichmann, B. Falkenburger (Dresden, Germany)

    Objective: Determine fear of progression (FoP) and its influencing factors in Parkinson's disease (PD) patients to alleviate the psychosocial distress it induces. Background: PD patients…
  • MDS Virtual Congress 2021

    Prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative cohort.

    P. Beach, J. Mckay (Atlanta, USA)

    Objective: To assess prevalence of neurogenic and peripheral orthostatic hypotension (nOH/pOH) in the PPMI (https://www.ppmi-info.org) idiopathic Parkinson disease (PD) cohort and to examine whether nOH,…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley